Noncoding RNAs in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed)

Funding Opportunity RFA-AG-23-011 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to stimulate research in noncoding ribonucleic acids (ncRNAs) to investigate the causality, directionality, mechanisms, and therapeutic potential of ncRNAs implicated in Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD). This FOA will support exploratory and developmental Grant (R21) applications seeking to discover functional roles of ncRNAs and underlying mechanisms involved in the pathogenesis and progression of AD/ADRD. Proposed studies should focus on functional characterization and mechanistic investigation of previously identified ncRNAs.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding